Welcome to the e-CCO Library!

P278: Short and long-term surgical outcomes and pouch function following proctocolectomy and pouch formation in paediatric ulcerative colitis: a multicentre-retrospective cohort study from the Porto IBD working group of ESPGHAN
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Orlanski Meyer E.*1, Topf-Olivestone C.1, Shtayer E.1, Tulchinsky H.2, Hansen L.-F.3, Kindermann A.4, Assa A.5, Kolho K.-L.6, Kolaček S.7, Carroll M.W.8, Martinelli M.9, Aloi M.10, Hansen R.11, Winter H.S.12, Navas-Lόpez V.M.13, Weiss B.14, Shah N.15, Turner D.1

Created: Wednesday, 20 February 2019, 10:36 AM
P278: Type IV collagen formation/degradation ratio predicts response to infliximab induction therapy in patients with Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Bourgonje, A.R.(1);Alexdottir, M.(2);Loveikyte, R.(1);Bay-Jensen, A.C.(2);van Dullemen, H.M.(1);Visschedijk, M.C.(1);Festen, E.A.M.(1);Weersma, R.K.(1);Karsdal, M.A.(2);Faber, K.N.(1);Mortensen, J.H.(2);Dijkstra, G.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P279 Early detection of mucinous adenocarcinoma within fistulating peri-anal Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Corr1, L. Reza2, P. Lung1, I. Jenkins3, A. Antoniou3, A. Latchford4, A. Wilson4, N. Arebi4, D. Burling1, J. Warusavitarne3, O. Faiz3, S. Thomas-Gibson4, A. Hart4, P. Tozer2

Created: Thursday, 30 January 2020, 10:12 AM
P279: Children born to mothers with inflammatory bowel disease – Is there any risk for newborns' complication and development during the childhood?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Farkas K.*1, Szántό K.1, Vass N.2, Szűcs D.2, Demcsák A.2, Lada S.1, Nyári T.3, Milassin A.1, Rutka M.1, Bor R.1, Bálint A.1, Fábián A.1, Nagy F.1, Szepes Z.1, Marik A.1, Molnár T.1

Created: Wednesday, 20 February 2019, 10:36 AM
P279: Crohn’s disease-associated small bowel carcinomas show distinctive histologic and phenotypic features: an Italian multicentric study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Di Sabatino*1, A. Vanoli2, F. Grillo3, C. Mescoli4, G. Nesi5, P. Giuffrida1, C. Papi6, O. Luinetti2, G. Sampietro7, G. Latella8, P. Fociani9, F. Tonelli5, R. Cannizzaro10, L. Coppola6, R. D’Incà4, G. Monteleone11, L. Biancone11, G. Solina12, V. Villanacci13, M. Martino1, A. Orlandi11, A. Rizzo12, M. Salemme13, M. Astegiano14, P. Migliora14, M. Rugge4, R. Fiocca3, G.R. Corazza1, E. Solcia2

Created: Friday, 22 February 2019, 9:49 AM
P279: Ileo-caecal stenosis in Crohn's disease: correlation between imaging, biology and endoscopy : preliminary results of a prospective study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Azzouzi, D.(1)*;
Created: Friday, 14 July 2023, 11:05 AM
P279: Interest of serum calprotectin in inflammatory bowel disease (IBD): a prospective monocentric study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Di Bernardo*1, A. Haccourt1, P. Veyrard1, E. Del Tedesco1, J. M. Phelip1, N. Williet1, S. Paul1, X. Roblin1

Created: Friday, 22 February 2019, 9:41 AM
P279: Potential of managed care programmes for patients with inflammatory bowel diseases – results from a large survey study among physicians and IBD-patients in Germany, Austria and Switzerland (the EASEIBD study)
Year: 2021
Source: ECCO'21 Virtual
Authors: Bokemeyer, B.(1);Kaiser, C.(2);Primas, C.(3);Novacek, G.(3);Biedermann, L.(4);Seibold, F.(5);Tappe, U.(6);Bettenworth, D.(7);Graw, J.(2);Hartmann, P.(8);Plachta-Danielzik, S.(9);Schultz, C.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P279: Prevalence of iron deficiency in inflammatory bowel disease
Year: 2022
Source: ECCO'22
Authors: Resál, T.(1);Bacsur, P.(1);Lupas, D.(2);Szántó, K.(1);Rutka, M.(1);Fábián, A.(1);Bor, R.(1);Szepes, Z.(1);Farkas, K.(1);Varga, M.(2);Molnár, T.(1);
Created: Friday, 11 February 2022, 3:52 PM
P279: Vedolizumab is safe for use in pregnant patients with IBD; report of our preliminary data
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Bar-Gil Shitrit1*, B. Koslowsky2, Y. Milgrom2, A. Lahat3, E. Goldin2, S. Granovsky- Grisaru4

Created: Thursday, 21 February 2019, 9:14 AM
P280 Sodium picosulfate low-volume and split-dosed bowel preparation facilitates endoscopic monitoring of patients with inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Fasoulas, A. Katsimpeli, P. Kevrekidou, N. Kafalis, E. Stergiou, S. Bouzoukas, G. Lazaraki, D. Tzilves, K. Soufleris

Created: Thursday, 30 January 2020, 10:12 AM
P280: Endoscopic training leads to a significant increase in agreement of endoscopic scoring for inflammatory bowel disease: results of the IGIBDEndo educational project
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Daperno*1, M. Comberlato2, F. Bossa3, L. Biancone4, A. Bonanomi5, A. Cassinotti6, R. Cosintino7, R. Mangiarotti7, G. Lombardi8, A. Papa9, R. Pica10, M. Rabagliati11, L. Grassano11, M. Gasparini11, G. Pagana11, R. D’Incà12, A. Orlando13, F. Rizzello14

Created: Friday, 22 February 2019, 9:49 AM
P280: Introduction of subcutaneous infliximab CT-P13 and vedolizumab in daily clinical practice: outstanding questions demonstrate the need for post-marketing studies
Year: 2021
Source: ECCO'21 Virtual
Authors: Ferrante, M.(1,2);Sabino, J.(1,2);Lobaton, T.(3);Dreesen, E.(4);Hoefkens, E.(5);Fierens, L.(2);Liefferinckx, C.(6);
Created: Wednesday, 2 June 2021, 4:12 PM
P280: Prediction factors for low bone mineral density in children with Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

N. Ronel1, A. Guz-Mark2, A. Assa2, R. Lev Zion1, E. Shteyer1, D. Strich1, D. Turner1, O. Ledder*1

Created: Friday, 22 February 2019, 9:41 AM
P280: Prognosis of patients with Crohns Disease in transmural remission with gastrointestinal ultrasound
Year: 2022
Source: ECCO'22
Authors: Nylund, K.(1);Sævik, F.(1);von Volkmann, H.L.(2);Gilja, O.H.(1);
Created: Friday, 11 February 2022, 3:52 PM
P280: Quality of life in military patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ben Safta, N.(1)*;Medhioub, A.(1);Mohamed, G.(1);Boughoula, K.(1);Ben Slimane, B.(1);Ben Abdallah, H.(1);Bouali, R.(1);Bizid, S.(1);Abdelli, M.N.(1);
Created: Friday, 14 July 2023, 11:05 AM
P280: Reducing the overprescribing of oral corticosteroids in IBD using a steroid assessment tool
Year: 2018
Source: ECCO '18 Vienna
Authors:

G. Scott1*, N. Roads1, W. Lewis2

Created: Thursday, 21 February 2019, 9:14 AM
P280: Therapeutic drug monitoring of infliximab and adalimumab for detection of patients at risk of loss of response in inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Gonzalez-Lopez J.1, Giráldez-Montero J.M.1, Ferreiro R.2, Lorenzo A.2, Lamas M.J.1, Dominguez-Munoz J.E.2, Barreiro-de Acosta M.*2

Created: Wednesday, 20 February 2019, 10:36 AM
P281 A serum biomarker panel can accurately identify the presence of mucosal ulcers in patients with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. HOLMER, B. Boland, S. Singh, J. Neill, H. Le, A. Miralles, A. Collins, W. Sandborn, P. Dulai

Created: Thursday, 30 January 2020, 10:12 AM
P281: Combined clinical and biological response (concomitant CRP and faecal calprotectin reductions) in induction and maintenance from the phase 3 ustekinumab Crohn’s disease studies
Year: 2018
Source: ECCO '18 Vienna
Authors:

J.-F. Colombel1*, C. Gasink2, A. Oortwijn3, R. van Kruchten3, S. Sloan2, V. Laliman4, P. Rutgeerts5, S. Ghosh6, W. Sandborn7, B. Feagan8, B. Sands1

Created: Thursday, 21 February 2019, 9:14 AM